Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease
Brochard 1995 trial design and results
Design
Randomised controlled trial in intensive care
Treatment
Non-invasive ventilation plus standard therapy
Control
Standard therapy alone
Population
85 patients with acute exacerbations of COPD, selected from 275 admitted over the same period
Follow-up
Hospital admission
Primary endpoint
Need for endotracheal intubation
Result
Non-invasive ventilation significantly reduced the need for endotracheal intubation, the length of hospital stay, and in-hospital mortality.
Secondary endpoints
Length of hospital stay, in-hospital mortality, complications
In selected patients with acute exacerbations of chronic obstructive pulmonary disease, noninvasive ventilation can reduce the need for endotracheal intubation, the length of the hospital stay, and the in-hospital mortality rate.
The trial authors, in the published abstract
How it has aged
The trial that created acute non-invasive ventilation as a therapy, and still the strongest indication for it. Note 'selected': 85 of 275 admitted patients were enrolled. NIV in hypercapnic COPD remains the one setting where the evidence is unambiguous — contrast FLORALI and 3CPO in other forms of respiratory failure.
Publications
Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease
Brochard L, Mancebo J, Wysocki M, et al. Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. N Engl J Med 1995 Sep 28;333(13):817-22.